Filing Details

Accession Number:
0001161697-16-000939
Form Type:
13G Filing
Publication Date:
2016-06-27 17:04:48
Filed By:
Kenwood Capital Llc
Company:
Globestar Therapeutics Corp (OTCMKTS:GSTC)
Filing Date:
2016-06-27
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Kenwood Capital 10,000,000 0 10,000,000 0 10,000,000 33.31%
Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


SCHEDULE 13G


Under the Securities Exchange Act of 1934



AngioSoma, Inc.

(Name of Issuer)



Common Stock

(Title of Class of Securities)



03476L102

(CUSIP Number)



June 22, 2016

(Date of Event Which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


[  ]  Rule 13d-1(b)

[X]  Rule 13d-1(c)

[  ]  Rule 13d-1(d)


* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)




CUSIP No.   03476L102



1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)


Kenwood Capital LLC

81-5736490

 

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*


(a) [ ]

(b) [ ]

 

 

3.

SEC USE ONLY

 

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION


Wyoming

 

 

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5. SOLE VOTING POWER

10,000,000

 

 

 

 

6. SHARED VOTING POWER

0

 

 

 

 

7. SOLE DISPOSITIVE POWER

10,000,000

 

 

 

 

8. SHARED DISPOSITIVE POWER

0

 

 

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


10,000,000

 

 

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES


[ ]

 

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


33.31%

 

 

12.

TYPE OF REPORTING PERSON


IN


- 2 -



Item 1.

 

(a)

Name of Issuer


AngioSoma, Inc.

 

 

 

 

(b)

Address of Issuer’s Principal Executive Offices


14001 Walden Rd., Suite 600

Montgomery, TX  77356

 

Item 2.

 

(a)

Name of Person Filing


Kenwood Capital LLC

 

 

 

 

(b)

Address of Principal Business Office or, if None, Residence


412 N. Main Street, Ste 100

Buffalo, WY  82834

 

 

 

 

(c)

Citizenship


Wyoming

 

 

 

 

(d)

Title of Class of Securities


Common stock

 

 

 

 

(e)

CUSIP Number


03476L102

 

 

Item 3.

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

 

 

 

 

 

(a)

[ ]

Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

 

 

 

 

 

(b)

[ ]

Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

 

 

 

 

 

(c)

[ ]

Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

 

 

 

 

 

(d)

[ ]

Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

 

 

 

 

(e)

[ ]

An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);

 

 

 

 

 

(f)

[ ]

An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);

 

 

 

 

 

(g)

[ ]

A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);

 

 

 

 

 

(h)

[ ]

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

 

 

 

 

(i)

[ ]

A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

 

 

 

 

(j)

[ ]

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).


- 3 -



Item 4.

Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

 

 

 

(a)

Amount Beneficially Owned:

 

 

 

10,000,000 shares of common stock

 

 

 

 

(b)

Percent of Class:

 

 

 

33.31%

 

 

 

 

(c)

Number of shares as to which such person has:

 

 

 

 

 

(i)

sole power to vote or to direct the vote

10,000,000

 

 

 

 

 

(ii)

shared power to vote or to direct the vote

0

 

 

 

 

 

(iii)

sole power to dispose or to direct the disposition of

10,000,000

 

 

 

 

 

(iv)

shared power to dispose or to direct the disposition of

0


Item 5.

Ownership of Five Percent or Less of Class.

 

 

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]

 

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

 

 

Not Applicable

 

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

 

 

 

Not Applicable

 

 

Item 8.

Identification and Classification of Members of the Group.


Not Applicable. This schedule is not being filed pursuant to Rule 13d-1(b)(1)(ii)(J) or Rule 13d-1(d).

 

 

Item 9.

Notice of Dissolution of Group.


Not Applicable

 

 

Item 10.

Certification.


By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


- 4 -



SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.



Kenwood Capital LLC


By: /s/ Robert L. Sonfield, Jr.

Date: June 27, 2016

Name: Robert L. Sonfield, Jr.

Title: President


- 5 -